Playbook Atlas/Opportunities/Lane Hub

Consumer

Lane-level opportunity view across countries and weekly pulses, backed by published signals and evidence lockers.

All opportunities

Published Opportunities

Visible Results

Countries

Weeks

Country Filter

All Countries Brazil4

State Filter

All States Validated2 Act Now1 Triangulated1

Week Filter

All Weeks Apr 17, 20264

Act NowConsumer Brazil Apr 17, 2026

The 'Ozempic Support Stack' for Muscle Preservation

Clinical data shows Eli Lilly's tirzepatide causes significant lean muscle loss compared to semaglutide. This creates a massive secondary market for 'muscle-sparing' supplements and protocols for the millions on GLP-1s.

sagavibecodewhatscold

Opportunity

Confidence

Country

Brazil

Top Countries in this Lane

Brazil

4 opportunities